Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
12,454 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,151 Million
Pharmaceuticals & Biotechnology
ILS 121,705 Million ()
12.00
NA
0.00%
1.57
41.08%
4.68






